Protonix - 0008-0923-55 - (PANTOPRAZOLE SODIUM)

Alphabetical Index


Drug Information of Protonix

Product NDC: 0008-0923
Proprietary Name: Protonix
Non Proprietary Name: PANTOPRAZOLE SODIUM
Active Ingredient(s): 40    mg/10mL & nbsp;   PANTOPRAZOLE SODIUM
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Protonix

Product NDC: 0008-0923
Labeler Name: Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020988
Marketing Category: NDA
Start Marketing Date: 20010501

Package Information of Protonix

Package NDC: 0008-0923-55
Package Description: 10 CARTON in 1 PACKAGE (0008-0923-55) > 1 VIAL in 1 CARTON (0008-0923-51) > 10 mL in 1 VIAL

NDC Information of Protonix

NDC Code 0008-0923-55
Proprietary Name Protonix
Package Description 10 CARTON in 1 PACKAGE (0008-0923-55) > 1 VIAL in 1 CARTON (0008-0923-51) > 10 mL in 1 VIAL
Product NDC 0008-0923
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name PANTOPRAZOLE SODIUM
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20010501
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Substance Name PANTOPRAZOLE SODIUM
Strength Number 40
Strength Unit mg/10mL
Pharmaceutical Classes Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]

Complete Information of Protonix


General Information